scispace - formally typeset
A

Akbar Panju

Researcher at McMaster University

Publications -  49
Citations -  8912

Akbar Panju is an academic researcher from McMaster University. The author has contributed to research in topics: Venous thrombosis & Pulmonary embolism. The author has an hindex of 30, co-authored 49 publications receiving 8531 citations. Previous affiliations of Akbar Panju include Hamilton Health Sciences & McMaster-Carr.

Papers
More filters
Journal ArticleDOI

Pharmacological Management of Chronic Neuropathic Pain – Consensus Statement and Guidelines from the Canadian Pain Society

TL;DR: Randomized, controlled trials, systematic reviews and existing guidelines focusing on the pharmacological management of NeP were evaluated at a consensus meeting and recommendations for treatment are based on degree of evidence of analgesic efficacy, safety, ease of use and cost-effectiveness.
Journal ArticleDOI

Heparin for 5 Days as Compared with 10 Days in the Initial Treatment of Proximal Venous Thrombosis

TL;DR: It is concluded that a five-day course of heparin is as effective as a 10- day course in treating deep venous thrombosis and furthermore, using the shorter course would permit earlier discharge from the hospital and thus offer substantial cost savings.
Journal ArticleDOI

The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease.

TL;DR: It is demonstrated that thienopyridines are effective in reducing vascular events when compared with placebo/control or aspirin, as well as when used in combination with aspirin in patients undergoing intracoronary stent implantation.
Journal ArticleDOI

A noninvasive strategy for the treatment of patients with suspected pulmonary embolism.

TL;DR: The findings indicate that the clinician has a practical noninvasive strategy in patients with adequate cardiorespiratory reserve and nondiagnostic lung scans that avoids pulmonary angiography, identifies patients with proximal-vein thrombosis who require treatment, and avoids the need for treatment and further investigation in the majority of patients.